GlomCon Seminar Archive

GlomCon Seminars, Conferences, and Roundtable Discussions

Support GlomCon through your membership and join a growing network of healthcare professionals, trainees, and fellow alumni.

Glomerular Diseases

Topic-based

1. Common Vascular and Endothelial Injuries
2. A Potpourri of Cases from the Collection of Dr. Bijol
3. An Interactive Live Exhibition from the Collection of Dr. Bijol
4. AKI with Hematuria and Proteinuria in a Middle-aged Women with a Solitary Kidney
5. Apolipoprotein E Gene - Polymorphism and CKD
6. Not Everything Under One Umbrella
1. Clinical Presentation, Natural History, and Management of Inherited Disorders of GBM
2. Alport Spectrum Disorders
1. Renal Amyloidosis: Presentation, Diagnosis, and Management
1. ANCA GN - A Case-based Discussion
2. Classification and Diagnosis of Vasculitis Affecting the Kidneys
3. Management of ANCA GN: A 2022 Update
4. Pauci-immune Glomerulonephritis
5. Pauci-immune Glomerulonephritis - Overview and Updates
6. The Art of Treating ANCA Vasculitis
7. Comorbidities in ANCA-Associated Vasculitis
8. Update on Treatment of ANCA-associated Vasculitis and Future Perspectives
9. ANCA-Associated Vasculitis 2024
1. Dual ANCA and Anti-GBM Positivity: A Case-based Discussion
2. The Pathology of Crescentic GN and Anti-GBM
3. Management of Anti-GBM: A Case-based Discussion
1. Management of Anti-phospholipid Syndrome
2. Anti-phospholipid Nephropathy: A 2023 Update
1. Barriers to Woman in Medicine, Nephrology, and Academia
1. The Kidney in Aging and the Diagnosis of CKD
1. C3 Glomerulopathy
2. MPGN Pattern of Injury
3. The Pathology of Complement Mediated Glomerulopathy
4. Management of C3 Glomerulopathy
5. Overview of MPGN Pattern Pathology and an In-depth Focus on C3GN
6. Clinical Management of C3 Glomerulopathy
7. MPGN and C3 Glomerulopathy
8. Understanding MPGN and C3 Glomerulopathy
9. PGNMID or C3 GN? - Case discussion
10. C3 Glomerulopathy: In the Native Kidney and Post-Transplant
11. Updates in Complement Biology in Health, Disease, and Therapeutics
1. Pathology Imaging and Informatics: Experience with the NIDDK Kidney Precision Medicine Project
2. Computational Nephropathology: Session 1
3. Computational Nephropathology: Session 2
4. Computational Nephropathology: From Basics to Applications (I)
5. Computational Nephropathology: From Basics to Applications (II)
6. Development and Validation of a Renal Risk Score in ANCA-Associated Glomerulonephritis
7. Computational Pathology of FSGS and MCD
8. Pathomics and Next Generation Morphometry
9. Integrating spatial omics and computationally derived characteristics of functional tissue units and cells (FUSION)
10. Morpho-omic Integration and Clinical Deployment
11. Progressing Towards Automated Banff Scoring
1. COVID-19 Mitigation and Support in Patients with CKD & ESRD
2. COVID-19 Mitigation and Support Strategies in Patients with GN or Transplant
3. COVID-19 Vaccine and GN
4. Latest Insights into the Epidemiology of COVID-19 in Nephrology from ERACODA
5. COVID-19 Associated Renal Disease
6. Approaching Nephrotic Syndrome after COVID-19 Immunization
1. Diagnosis and Management of Cryoglobulinemic GN
2. The Pathology of Cryoglobulinemic Glomerulonephritis
3. Sudden Onset Nephrotic Syndrome and AKI in a Patient with HIV
1. Diabetic Kidney Disease: Circa 2018
2. The Pathology of Diabetic Kidney Disease
3. Renal Biopsy in Diabetic Patient - A Case-based Discussion
4. Getting Ready for Flozins: 2022 Version
5. New Glucose-Lowering Drugs and Kidney Protection in CKD
6. SGLT2 inhibition in Diabetic Kidney Disease: 2017
7. Kidney Biopsy in Type 2 Diabetes. Any Novelties?
8. Biopsy or Not Biopsy in Patients with Diabetes and Kidney Disease
9. Obesity-Related Glomerulopathy and Diabetic Nephropathy Similarities and Differences
1. Cutting Thru the Hype and Promoting Objectivity
2. Non-invasive Monitoring of Kidney Transplant Recipients
3. HLA Typing and Detection of Sensitized Recipients
4. The Molecular Microscope
5. More than Meets the Eye
1. AI in Renal Pathology
2. Complete Digitization of The Kidney Biopsy
1. Drug-induced Lupus
2. The Nephropathology of Drug Abuse
3. AKI and Hemoptysis: A Case of Autoimmune Proportions
1. Fabry Disease - A Case-based Discussion
2. Fabry Disease: A CPC
1. A Primer on Fibrillary GN for Fellows
2. Fibrillary GN and Amyloidosis
3. The Spectrum of Fibrillary GN
4. DNAJB9-Fibrillary Glomerulonephritis
1. Why is the Diagnosis of "Hypertensive Nephrosclerosis" a Fallacy and a Cop-out?
1. Antibody Mediated Rejection
2. Principles in Alloimmunity
3. Chronic Antibody Mediated Rejection: Insights from Spatial Molecular Profiling
4. Mechanistics of Kidney Allograft Rejection
5. Kidney Allograft Tolerance: Close to Prime Time?
1. Immunosupressive Management of the Kidney Transplant Recipient
2. Vaccine Responses in Immunocompromised Individuals
1. IRGN - A Case-based Discussion
2. The Pathology of IRGN
3. Management of IRGN (Part I)
4. Management of IRGN (Part II)
5. Management of IRGN (Part III)
6. Management of (Viral) IRGN
7. Infection, IgA deposits, Crescents, ANCA – the diagnostic conundrum
8. Hepatitis C Virus-Related Glomerulonephritis: An Update
1. Renal Biopsy Pathology of IgA Nephropathy
2. A Case-based Discussion on HSP and IgA Vasculitis
3. IgA Nephropathy and Henoch-Schoenlein Purpura
4. Management of IgA Nephropathy 2019
5. An Update on IgA Nephropathy Therapeutics
6. Secondary IgA Nephropathy - Reality or Illusion
7. Translating New Trials in IgAN
8. IgA Nephropathy: Developing a Non-Immunosuppressive Therapy
9. The Treatment of IgAN: What’s the Latest?
10. SPARSENTAN In IgA Nephropathy: An Update On The Clinical Trials
11. IgAN and IgA Dominant Glomerulopathies - KM55 as a Tissue Biomarker for Differentiation
1. Sleepless in Seattle - A Case-based Discussion
1. The Guiding Principles for Evaluation of Glomerular Disorders
2. Urine Microscopy
3. Introduction to Renal Pathology (Part I)
4. Introduction to Renal Pathology (PartII)
5. Introduction to Renal Pathology (Part III)
6. The Renal Biopsy in the Era of Precision Medicine
7. Digging Deeper in Renal Pathology
8. Embracing the Heterogeneity of Nephrotic Syndrome
9. Genetic Causes of Glomerular Kidney Disease
10. Prophylaxis in Glomerular Diseases
11. ESRD Due to a History of GN. What Next?
12. Super-Resolution Microscopy and More
13. Artificial Intelligence and Clinical Decision Support in Kidney Transplantation
14. Kidney Potpourri: A selection of renal biopsy cases
15. Spatial Transcriptomic Approaches to Kidney Disease
16. Proteomics in Kidney Disease
17. The Kidney Biopsy: An introduction for nephrologists
18. Laboratory Management in Renal Pathology
19. I wasn’t expecting THAT! - When clinical presentation and kidney biopsy disagree with each other, who gets the last word?
20. As far as we can go - From Pathology to Genetics - Interesting cases from the practice
21. Renal Manifestations in Rheumatologic Diseases
22. The Value of Electron Microscopy in Renal Pathology
23. The Evolution of the Renal Biopsy Evaluation
24. Rituximab Related Complications A Closer Look at a Familiar Tool
1. Monoclonal Gammopathy Associated Diseases in Renal Pathology
1. Management of Lupus Nephritis: A Case-based Discussion
2. The Pathology of LN and Lupus Podocytopathy
3. Update on Membranous Lupus Nephritis
4. Lupus Nephritis and Lupus Podocytopathy
5. The Spectrum of Lupus Nephritis: A Case-based Discussion
6. Lupus Nephritis - Good News Stories
7. Lupus Nephritis and Related Conditions
8. Lupus Nephritis Classification - How can we improve?
9. Lupus Nephritis and Idiopathic Full-House Glomerulonephritis
10. Lupus Nephritis: To Be or Not to Be
11. 2023 Challenges in SLE
12. Precision Medicine in Lupus Nephritis
13. Lost in Translation: The Lupus Nephritis Classification over the years
1. The Podocytopathies: MCD and FSGS
2. Clinical Management of MCD
3. Clinical Management of FSGS
4. A Case of Focal Segmental Glomerulosclerosis
5. FSGS: Should Genetics Guide our Intervention
6. FSGS: A Clinicopathological Correlation and Case-based Approach Toward the Correct Diagnosis
7. Prognosis and Management of Primary FSGS
8. Old and New Ways of Understanding FSGS
9. Minimal Change Disease Reimagined
10. APOL1 - Toward Precision Medicine Approaches
11. Bench-to-Bedside-Bench Studies in Familial Nephrotic Syndrome
12. Anti Nephrin-Mediated Podocytopathy – More Than A Minimal Change
13. Viral Cytokine Storms and Glomerular Disease
14. A Clinical-pathological Approach to Differentiate Primary, Secondary, and Genetic FSGS
15. Rituximab in Adult Podocytopathies - The rationale for its use, efficacy data, and outlook
16. Protective effect of variant p.N264K in the APOL1 gene against APOL1 medicated kidney disease (AMKD)
17. Focal and Segmental Glomerulosclerosis. A need for better phenotyping patients
18. Reaching for Primary FSGS and studying their disease journey within a diverse population in the USA
1. The Pathology of Membranous Nephropathy
2. Clinical Management of Membranous Nephropathy
3. Membranous Nephropathy - A Case-based Discussion
4. Management of Membranous Nephropathy After Mentor
5. Precision Medicine- A serology guided approach to treatment of PLA2R associated Membranous Nephropathy
6. Discovery of ‘New’ Antigens in Membranous Nephropathy
7. Membranous Nephropathy: Novel Treatments Paradigms
1. Stone Disorders and Crystal Nephropathy
2. Contrast-induced Nephropathy
3. The Older Adult Receiving RRT: A Roundtable Discussion
4. The Pathology of Tubulointerstitial Nephritis
5. Tubulointerstitial Disorders
6. Caffeine Consumption and Mortality in CKD
7. CKD Hotspots around the World
8. Sodium Bicarbonate and Cardiovascular Events in Hypertensive Adults
9. PKD Throughout Life
10. MRI to Assess Renal Tissue Oxygenation and Function
11. Trends in Excess Mortality in European Adult Patients on RRT
12. What is behind a Granulomatous TIN?
13. The Pathology and Pathogenesis of CKDu
14. Tubular Toxins: Origins and Kidney Consequences
15. Platelets in Kidney Injury and Repair – insights from preclinical research
1. Renal Effects of Novel Anti-cancer Drugs
2. Onconephrology Potpourri
3. Renal Involvement in Lymphoproliferative Disorders
4. Onconephrology Update
5. Check Point Inhibitor Associated Renal Disease
6. Renal Toxicity Associated with New Immunotherapies
7. Kidney Injury Post Stem Cell Transplant
8. Hypercalcemia Associated with Immune-Checkpoint Inhibitors
9. The Renal Pathology of Check Point Inhibitors
10. Kidney Adverse Effects of Anti-Tumor Therapy
1. Atypical Anti-GBM due to monoclonal IgG
2. Waldenstrom's Macroglobulinemia: A Case-based Discussion
3. Fibrillary GN and Amyloidosis
4. Pathology of Paraprotein Mediated Kidney Disease
5. A Case-Based Approach to Diagnosis and Management of MGRS
6. Clinical Presentation, Differential, and Therapy of MGRS
7. An Update on the Classification and Pathologic Diagnosis of MGRS Lesions
8. The Differential Diagnosis of MGRS
9. The Startling Confessions of a Kidney Biopsy
10. When to Suspect MGRS in a Patient with Positive Monoclonal Studies?
11. A Tale of Two Light Chains
12. The Tissue Patterns of Monoclonal Deposits
13. Current Approaches in the Treatment of MGRS
14. Renal Amyloidosis: Presentation, Diagnosis, and Management
1. Risk Factors Associated with Post-Kidney Transplant Malignancy
2. Viral Infections in the Renal Allograft
3. Transplant Onconephrology
4. 2023 Updates on CMV Management after Kidney Transplant
5. Microvascular inflammation of the Kidney Allograft
6. BK Virus Nephropathy: An Update
7. Pregnancy and Kidney Transplantation
8. Chronic AMR in Kidney Transplant Recipients
9. HCV + Kidney Transplantation
10. HCV Infection in Kidney Transplantation
1. Proteinuria: A Case-based Discussion
2. Glomerular Disease in Pregnancy
3. The Pathology of Kidney Disease in Pregnancy
1. Advances in APOL1 Therapeutics
2. APOL1: A Story from Bench to Bedside
3. APOL1 Mediated Kidneys Disease in Autoinmune Conditions
1. C3 Glomerulopathy
2. Targeting C3 and IC Glomerulopathies: Pegcetacoplan
1. Diabetic Nephropathy
1. IgA Nephropathy
2. Emerging Therapies for IgA Nephropathy
3. IgAN & FSGS
4. IgA Nephropathy: Developing a Non-Immunosuppressive Therapy
1. Lupus Nephritis
2. Lupus Nephritis Trial Design and Execution
1. FSGS (I)
2. FSGS (II)
3. Targeting the Podocyte as a Treatment Approach for FSGS
4. IgAN & FSGS
5. A Clinical Trial in Primary FSGS
6. Emerging Science in Kidney Disease with Pfizer
1. Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant
1. The Use of Race in eGFR and More: Is it Essential or Race Essentialism?
1. Recurrent Glomerulonephritis
2. Post-Transplant Recurrent Primary Glomerular Diseases
3. Post-transplant Recurrence of Glomerular Diseases
1. Clinical Trials 101
2. Practical Pearls for Trial Recruitment
3. Disparities in Clinical Research
4. Clinical Trials Drug Development for all Ages
5. The Road to Glomerular Disease Therapeutics
6. Fireside chat with Dr. Aliza Thomson
7. Pathology and Clinical Trials
8. Immune Tolerance Network and The Advancement of Clinical therapies: A Closer Look at Membranous Nephropathy
1. TMA - A Case-based Discussion
2. TMA/TTP/HUS - Scleroderma Renal Disease - Antiphospholipid Syndrome
3. Management of TMA/TTP/HUS
4. Scleroderma Renal Crisis
5. Can a Man Get Preeclampsia?
6. Thrombotic Microangiopathy - An Update for the Practicing Physician
7. Thrombotic Microangiopathy
1. Equity, Utility, and the Kidney Transplant Allocation System
2. Trends in European Kidney Transplantation Rates
1. Comprehensive Kidney Transplant Care
2. What is really causing disparities in access to kidney transplantation?
3. Equity in Kidney Transplantation
1. The Pathology of Transplant Rejections
2. The Banff Kidney Transplant Pathology Classification
3. T-Cell Mediated Rejection
4. Nephrotoxic Manifestation of Drug in the Renal Allograft
5. Renal Allograft Biopsies: How to Deal with the Scofflaws
6. Banff 2022: An Update
7. Updates in Transplant Onconephrology
8. Complement in Kidney Transplantation
9. Tissue Transcriptomics in Kidney Transplant Rejection-Continued Surprises
10. Personalized Approach to Kidney Transplant Candidates with Hematologic Malignancy
11. Spectrum of Transplant Rejection: Implementing a Scalable Framework of Activity and Chronicity
1. Kidney Xenotransplantation: Are We Close to Prime Time?
2. Ethics of Pig to Human Transplants, Artificial Intelligence, and Why the Future is Porcine

About this Program

280 lessons
300.5 hours of video content

Sign up

Support GlomCon through your membership and join a growing network of healthcare professionals, trainees, and fellow alumni.

Join

A Collection of Clinicopathological Correlations

Alport Syndrome

Amyloidosis

ANCA-associated Glomerulonephritis

Anti-GBM Disease

Anti-phospholipid Syndrome

Barriers to Women in Medicine

CKD Diagnosis

Complement-mediated Glomerular Diseases

Computational Pathology

COVID and the Kidney

Cryoglobulinemic Glomerulonephritis

Diabetic Kidney Disease

Diagnostics

Digital Pathology

Drug-induced Glomerulonephritis

Fabry Disease

Fibrillary Glomerulonephritis

Hypertensive Nephrosclerosis

Immune Tolerance and Rejection

Immunosuppressive Management

Infection-Related Glomerulonephritis

IgA Nephropathy and IgA Vasculitis

IgG4 -related Disease

Introduction and General Principles

Kidney Pathology

Lupus Nephritis

Minimal Change Disease/Focal Segmental Glomerulosclerosis

Membranous Nephropathy

Non-GN Related Sessions

Onconephrology

Paraprotein-associated Kidney Disease

Post-transplant Complications

Pregnancy and Glomerular Disorders

Progress in APOL1 Related Kidney Disease

Progress in Complement Mediated Glomerulopathy

Progress in Diabetic Nephropathy

Progress in IgA Nephropathy

Progress in Lupus Nephritis

Progress in Primary FSGS

Progress in Renal Transplant

Race-Based Medicine

Recurrence of Primary Disease

Regulatory and Operations

Thrombotic Microangiopathy

Transplant Allocation and Epidemiology

Transplant Clinic

Transplant Pathology

Xenotransplantation

About this Program